Major Depressive Disorder: A Guide for the Nurse Practitioner in Primary Care
This activity is supported by an educational grant from Otsuka America Pharmaceutical, Inc and Lundbeck.
On-demand CE Webinar
Travis A. Cos, PhD
Licensed Psychologist and Sr. Behavioral Health Consultant
Public Health Management Corporation Care Clinic
Department of Psychology
La Salle University
Nurse practitioners in primary care settings need to have a complete understanding of current and emerging strategies in the treatment and management of MDD. They need to be familiar with risk factors and tools available for screening patients to diagnosis and treat earlier. This is educational program will focus on MDD and review the most recent medications along with monitoring and promoting adherence to medications in order to provide a continuity of care.
At the completion of this activity, the participant will be able to:
Review treatments and monitoring strategies for MDD.
Be proficient in screening patients for depression and providing support as a gatekeeper for presenting patients.
Explain the reasons for nonadherence and be able to intercede appropriately
Targeted Audience: Nurse Practitioners Length of Webinar: 1 hour Release Date: February 8, 2017 Expiration Date: February 8, 2018 Fee: Free
How to Obtain Credit
To receive credit, participants must complete the online pretest, view the activity in its entirety, and complete the online post-test and activity evaluation form. After completing the online assessment tests, and completing the activity evaluation form, participants may request credit. All participants must request credit before February 8, 2018. CE credit will not be issued after this date.
Global Education Group is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 110121. This program has been approved for 1.0 contact hours of continuing education (which includes 0.5 hours of pharmacology). Activity ID# 2214E.
This activity was planned in accordance with AANP CE Standards and Policies.
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The following contributors have no relevant financial relationships with commercial interests to disclose.
Travis A. Cos, PhD
Pharmacy Times Continuing Education Planning Staff—David Heckard; Maryjo Dixon, RPh; Donna Fausak
Global Education Group
Kristen Delisi, NP, Lindsay Borvansky, Andrea Funk, Laura Gilsdorf
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and ArcMesa (PER) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Required: Mac OS® X 10.4.11 (Tiger®) or newer